US Equity Sector Plus
The Navellier U.S. Equity Sector Plus Portfolio is designed as a tactical, defensive strategy for investors who seek an allocation within the U.S. equity markets. The portfolio invests in ten equity sector ETFs and under certain circumstances takes defensive positions by investing in three bond ETFs staggered along the yield curve.
ETF Universe (By Sleeve)
|U.S. Equity ETFs|
|iShares® Consumer Discretionary||IYC|
|iShares® Consumer Staples||IYK|
|iShares® Health Care||IYH|
|iShares® Nasdaq Biotechnology||IBB|
Effective February 15, 2014, the following ETFs were added to the investment universe: Consumer Staples, Financial, Health Care, Biotechnology, and Nasdaq-100. Effective September 28, 2016, the following ETFs were added to the investment universe: Investment Grade Corporate Bonds and Convertible Bonds.
|Fixed Income ETFs/Defensive Positions|
|iShares® Barclays 20+ Year Treasury Bond||TLT|
|iShares® Barclays 7-10 Year Treasury Bond||IEF|
|iShares® Barclays 1-3 Year Treasury Bond||SHY|
|iShares® U.S. Real Estate||IYR|
|iShares® U.S. Utilities||IDU|
|SPDR Barclays Convertible Securities ETF||CWB|
|iShares® IBoxx $ Investible Grade Corporate Bond Fund||LQD|
*Navellier Tactical U.S. Equity Sector Plus accounts may invest in a cash equivalent, such as money market funds, in place of SHY.
CHIEF INVESTMENT OFFICER
Mr. Navellier’s stock selection process focuses on quantitative analysis, fundamental analysis, and optimization of the securities selected for the portfolio.
Mr. Garaventa manages the All Cap Core strategy and is a member of many portfolio management teams including, but not limited to the Large Cap Growth, Power Dividend, and Small-to-Mid Cap Growth management teams.
Performance results presented herein do not necessarily indicate future performance; investment in equity strategies involves substantial risk and has the potential for partial or complete loss of funds invested. Results presented include reinvestment of dividends and other earnings. None of the stock information, data and company information presented herein constitutes a recommendation by Navellier or a solicitation of any offer to buy or sell any securities. As a matter of normal and important disclosures to you, as a potential investor, please consider the following: The model performances presented in the accompanying charts and graphs are not based on any actual securities trading, portfolio, or accounts, and should be considered mere “paper” or proforma performance results based on Navellier’s research.